Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1846
Shaikh J, Ankola DD, Beniwal V, Singh D and Ravi Kumar MNV. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer European Journal of Pharmaceutical Sciences 2009, 37, 223-230.
1847
Sharma G, Abraham I, Pardasani R, Bharatam PV and Mukherjee T. A DFT and CASSCF Study of Photocycloaddition Reactions of Biradicals from 6-Amino-2-(3-Thienoyl)-1,4-Benzoquinone Bulletin of the Chemical Society of Japan 2009, 82, 1477-1488.
1848
Sharma R, Kaundal RK and Sharma SS. Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed guinea pigs Pulmonary Pharmacology & Therapeutics 2009, 22, 183-189.
1849
Sharma RK, Reddy RP, Tegge W and Jain R. Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides Journal of Medicinal Chemistry 2009, 52, 7421-7431.
1850
Sharma S, Singh G, Chavan HD and Dey CS. Proteomic analysis of wild type and arsenite resistant Leishmania donovani Experimental Parasitology 2009, 123, 369-376.
1851
Sharma SS, Kumar A, Arora M and Kaundal RK. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes Free Radical Research 2009, 43, 400-408.
1852
Sharma SS, Srinivasan SK, Krishnamoorthy S, Kaushal AM and Bansal AK. Preclinical safety pharmacological studies on the amorphous formulation of celecoxib Arzneimittel-Forschung 2009, 59, 254-262.
1853
Singh A, Basit A and Banerjee UC. Burkholderia cenocepacia: a new biocatalyst for efficient bioreduction of ezetimibe intermediate Journal of Industrial Microbiology and Biotechnology 2009, 36, 1369-1374.
1854
Singh A, Bhattacharyya MS and Banerjee UC. Purification and characterization of carbonyl reductase from Geotrichum candidum Process Biochemistry 2009, 44, 986-991.
1855
Singh G, Thakur M, Chakraborti PK and Dey CS. Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile International Journal of Antimicrobial Agents 2009, 33, 80-85.
1856
Singh JN, Jain G, Ramarao P and Sharma SS. Inhibition of sodium current by carbamazepine in dorsal root ganglion neurons in vitro Indian Journal of Physiology and Pharmacology 2009, 53, 147-154.
1857
Singh M, Singh RS and Banerjee UC. Stereoselective synthesis of (R)-1-chloro-3(3,4-difluorophenoxy)-2-propanol using lipases from Pseudomonas aeruginosa in ionic liquid-containing system Journal of Molecular Catalysis B: Enzymatic 2009, 56, 294-299.
1858
Singh R, Jhamb SS and Singh PP. Effect of morphine on Mycobacterium smegmatis infection in mice and macrophages Indian Journal of Microbiology 2009, 49, 276-282.
1859
Sundriyal S and Bharatam PV. Important pharmacophoric features of pan PPAR agonists: Common chemical feature analysis and virtual screening European Journal of Medicinal Chemistry 2009, 44, 3488-3495.
1860
Sundriyal S and Bharatam PV. Sum of activities' as dependent parameter: A new CoMFA-based approach for the design of pan PPAR agonists European Journal of Medicinal Chemistry 2009, 44, 42-53.
1861
Tikoo K, Ali IY, Gupta J and Gupta C. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats Toxicology Letters 2009, 191, 158-166.
1862
Tikoo K, Kumar P and Gupta J. Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats. BMC Cancer 2009, 9, (107) .
1863
Tripathi DN and Jena GB. Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: A study in mice Chemico-Biological Interactions 2009, 180, 398-406.
1864
Vats P, Bhushan B and Banerjee UC. Studies on the dephosphorylation of phytic acid in livestock feed using phytase from Aspergillus niger van Teighem Bioresource Technology 2009, 100, 287-291.
1865
Adyary F, P ivi O, Gupta H, Pia B, Anna G, Mohan CG and Pia MV. Inhibition of acetylcholinesterase by coumarins: The case of coumarin 106 Pharmacological Research 2008, 58, 215-221.
1866
Agrawal V and Roy N. Contaminating insert degradation by preincubation colony PCR: A method for avoiding false positives in transformant screening Analytical Biochemistry 2008, 375, 159-161.
1867
Agrawal V, Gupta B, Banerjee UC and Roy N. A method for construction, cloning and expression of intron-less gene from unannotated genomic DNA Molecular Biotechnology 2008, 40, 217-223.
1868
Arora M, Kumar A, Kaundal R and Sharma SS. Amelioration of Neurological and Biochemical Deficits by Peroxynitrite Decomposition Catalysts in Experimental Diabetic neuropathy European Journal of Pharmacology 2008, 596, 77-83.
1869
Ashokraj Y, Agrawal S and Panchagnula R. A decision tree for rapid quality assurance and control of rifampicin-containing oral dosage forms for global distribution for tuberculosis treatment Indian Journal of Pharmaceutical Sciences 2008, 70, 4-1.
1870
Ashokraj Y, Kaur KJ, Singh I, Kholi G, Bhade SR, Varma MVS, Agrawal S and Panchagnula R. In vivo dissolution: predominant factor affecting the bioavailability of rifampicin from its solid oral dosage forms Clinical Research and Regulatory Affairs 2008, 25, 12-1.
1871
Awale M and Mohan CG. 3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors Journal of Molecular Graphics and Modelling 2008, 26, 1169-1178.
1872
Awale M and Mohan CG. Molecular Docking Guided 3D-QSAR CoMFA Analysis of N-4-Pyrimidinyl-1H-indazol-4-amine Inhibitors of Leukocyte-specific protein tyrosine kinase Journal of Molecular Modeling 2008, 14, 937-947.
1873
Bahiru LA and Bharatam PV. Tautomeric preferences and electron delocalisation in biurets, thiobiuret and dithiobiuret: an ab initio quantum chemical study International Journal of Quantum Chemistry 2008, 108, 1277-1286.
1874
Bansal SS, Kaushal A and Bansal AK. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation Die Pharmazie 2008, 63, 812-814.
1875
Bhagat S and Chakraborti AK. Zirconium(IV) compounds as efficient catalysts for synthesis of α-aminophosphonates Journal of Organic Chemistry 2008, 73, 6029-6032.
1876
Bharate SB, Khan SI, Jacob MR, Tekwani BL, Khan IA and Singh IP. S-Euglobals: Biomimetic synthesis, antileishmanial, antimicrobial and antimalarial activities Bioorganic & Medicinal Chemistry 2008, 16, 1328-1336.
1877
Bhardwaj SP and Singh S. Study of forced degradation behavior of Enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay Method Journal of Pharmaceutical and Biomedical Analysis 2008, 46, 113-120.
1878
Bhatia RK, Kumar A and Tiwari P. Journal of Pharmacovigilance and Drug Safety 2008, 5, 89-94.
1879
Bhattacharyya MS, Singh A and Banerjee UC. Production of carbonyl reductase by Geotrichum candidum in a laboratory scale bioreactor Journal of Parasitic Diseases 2008, 99, 8765-8770.
1880
Bisht B and Dey CS. Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cells Indian Journal of Hospital Pharmacy 2008, 9, (48) .
1881
Bisht B, Srinivasan K and Dey CS. In vivo inhibition of focal adhesion kinase causes insulin resistance BVIMR Management Edge 2008, 586, 3825-3837.
1882
Butani KK, Manoj and Singh PP. Journal of Parasitic Diseases 2008, 32, 111-117.
1883
Chakraborti AK, Roy SR, Kumar D and Chopra P. Catalytic application of room temperature ionic liquids: [bmim][MeSO4] as a recyclable catalyst for synthesis of bis(indolyl)methanes Ion-fishing by MALDI-TOF-TOF MS and MS/MS studies to probe the proposed mechanistic model of catalysis Journal of Management and Information Technology 2008, 10, 1111-1118.
1884
Chankeshwara SV, Chebolu R and Chakraborti AK. Organocatalytic methods for chemoselective O-tert-butoxycarbonylation of phenols and their regeneration from the O-t-Boc derivatives Pharmbit 2008, 73, 8615-8618.
1885
Chawla G and Bansal AK. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives Pharmacopeial Forum 2008, 58, 257-274.
1886
Chebolu R, Chankeshwara SV and Chakraborti AK. Triphenylphosphine as a novel organo-catalyst for chemo-selective O-tert-butoxycarbonylation of phenols Indian Drugs 2008, 18, 1448-1455.
1887
Dhanaraj E, Bhansali A, Jaggi S, Dutta P, Jain S, Tiwari P and Ramarao P. Prevalence and predictors of metabolic syndrome in non-obese Asian Indians with newly detected type 2 diabetes mellitus Indian Drugs 2008, 106, 366-372.
1888
Dhanikula AB and Panchagnula R. Fluorescence anisotropy, FT-IR spectroscopy and 31-P NMR studies on the interaction of paclitaxel with lipid bilayers Drug Delivery Technology 2008, 43, 569-579.
1889
Dhanikula RS, Dhanikula AB and Panchagnula R. Thermoreversible liposomal poloxamer gel for the delivery of paclitaxel: dose proportionality and hematological toxicity studies Indian Journal of Hospital Pharmacy 2008, 63, 439-445.
1890
Francis SM, Sharma M, Mittal A and Bharatam PV. Design of benzene-1,2-diamines as selective inducible nitric oxide synthase inhibitors: A combined de novo design and docking analysis Indian Journal of Hospital Pharmacy 2008, 14, 215-224.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|42|45